Trana Discovery -- CARY, NC (February 16, 2010) – Trana Discovery, Inc., an anti-infective drug discovery technology company, today announced that it has begun proof of concept studies on a rapid diagnostic platform that could identify the presence of the vast majority of infection-causing bacteria and possibly fungi in under an hour. The concept uses transfer RNA (tRNA) to detect the presence of infectious microorganisms in patient samples and, if present, identify the species of the infecting organism. If successful, this diagnostic platform could accelerate the speed and accuracy of diagnosis and treatment of infectious diseases in virtually any care setting, including hospitals, outpatient clinics, and doctors’ offices.
